Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Renal Insufficiency, Chronic 1Lymphoma, Follicular 1Diabetes Mellitus 1

Interventions

Rocuronium 2ziprasidone 1perflutren 1peginesatide 1hematide 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Thalidomide 1Spironolactone 1Sevelamer 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Labetalol 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1High-Energy Shock Waves 1Haloperidol 1Fosfomycin 1Dexamethasone 1DM199 1Clozapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Renal Insufficiency, Chronic × DM199 × Clear all
NCT03795389 2021-09-13

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

DiaMedica Therapeutics Inc

Phase 1 Completed
33 enrolled
Lymphoid

Diabetes Mellitus, Lymphoma, Follicular, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡